Report cover image

Germany Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and In

Publisher Allied Market Research
Published Jun 02, 2023
Length 84 Pages
SKU # ALMR18790452

Description

Germany Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032


Glucose testing is an essential procedure as inappropriate glucose levels are indicator of serious medical issues. Glucose testing aids in diagnosis, prevention, and treatment of overweight or diabetes, low blood sugar, and high blood pressure. Point-of-care (PoC) glucose testing is an effective and rapid substitute to typical lab testing, with results available in less than ten minutes. The Germany point-of-care glucose testing market is projected to witness substantial traction during the forecast period in terms of revenue. Factors such as increase in awareness about pre-diabetes, unhealthy lifestyle, and surge in the elderly population are projected to surge the sales of glucose testing devices in Germany.

Rise in diabetes incidence in Germany is a major driver of the point-of-care glucose testing market. Blood glucose level testing is one of the most essential tests performed for quick detection and management of diabetes, which is increasing demand for point-of-care glucose testing devices in the country. In addition, surge in usage of wearable glucose testing gadgets for self-monitoring blood sugar levels is anticipated to offer growth opportunities in the market. However, limited reimbursement schemes and high cost of glucose testing devices are the major factors restraining the growth of the Germany point-of-care glucose testing market. In addition, short lifespan of glucose testing equipment and shortage of experienced technicians to operate the devices hamper the market growth. Furthermore, dearth of suitable infrastructure and lack of technological understanding in rural regions are expected to impede the growth of the Germany point-of-care glucose testing market.

The presence of several established players in the Germany point-of-care glucose testing market creates opportunities for market participants to launch innovative and technologically advanced products. Companies are investing in R&D to provide advanced products in terms of accuracy and efficiency, which is expected to increase their sales. Furthermore, boost in usage of smart glucose meters in clinics and hospitals is projected to open new market prospects. The trend of introducing new product offerings is anticipated to increase in the Germany point-of-care glucose testing market in the near future. In addition, manufacturers are expected to focus on launching products, which are cost-effective and offer advanced features to meet current customer needs. Product launches, investments, and collaborations are some of the other market strategies, which companies are projected to adopt in the market.

The Germany point-of-care glucose testing market is segmented on the basis of product type, application, and end user. By product type the market is divided into lancing devices & strips and blood-glucose meters. According to application, the market is bifurcated into type 1 diabetes and type 2 diabetes. As per end user, the market is classified into hospitals & clinics, home care settings, and others. Rise in prevalence of diabetes in the nation is increasing the demand for point-of-care glucose testing technology. In accordance with WHO forecast, the number of diabetics in Germany are expected to reach 3.2 million by 2035, presenting considerable opportunities for the Germany point-of-care glucose testing market.

Key market players are focusing on increasing their market presence through new product launches in the country. For instance, in March 2020, Abbott launched Freestyle Libre 2, a real time glucose monitoring system. The device offers various benefits in the form of improved precision and simplicity. In addition, the deployment of real time technology is expected to open new opportunities for industry players in the country. Product developments and partnerships are other market strategies adopted by key players in Germany point-of-care glucose testing market. For instance, in 2018, Roche Diagnostics and Novo Nordisk partnered to support the use of connected insulin pens in people with type 1 diabetes, which enables them to track and manage insulin dosage. The market players focus on leveraging technologies such as Artificial Intelligence (AI) for the development of advanced products. Pricing strategy adopted by companies in the Germany point-of-care glucose testing market is one of the key strategies for attaining profitability. The market players focus on offering cost-effective products to customers, targeting both private and public healthcare institutions. With competitive pricing, companies are able to garner a high share of the market. 

Key Benefits For Stakeholders

Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.

Analyze the key strategies adopted by major market players in Germany point-of-care glucose testing market.

Assess and rank the top factors that are expected to affect the growth of Germany point-of-care glucose testing market.

Top Player positioning provides a clear understanding of the present position of market players.

Detailed analysis of the Germany point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.

Identify key investment pockets for various offerings in the market.
Product Benchmarking / Product specification and applications
Upcoming/New Entrant by Regions
New Product Development/ Product Matrix of Key Players
Patient/epidemiology data at country, region, global level
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product Type

Lancing Devices and Strips
Blood-Glucose Meter
Type
Lifescan OneTouch Ultra and Lifescan OneTouch Verio
Accu-Chek Aviva Plus and Accuchek
Freestyle Lite and Freestyle Precission Neo
Contour Next
Others

By Application

Type-1 Diabetes
Type-2 Diabetes

By End User

Hospitals and Clinics
Home Care Settings
Others

Key Market Players

Roche
Abbott
Medtronic
Siemens Healthineers
Bayer
Novo Nordisk
Pentax Medical
OptiMedis
ZEISS Group
B. Braun Melsungen AG

Please Note: It will take 7-10 business days to complete the report upon order confirmation. 

Table of Contents

84 Pages
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
CHAPTER 5: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
CHAPTER 6: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Roche
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Abbott
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Medtronic
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Siemens Healthineers
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Bayer
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Novo Nordisk
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Pentax Medical
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. OptiMedis
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. ZEISS Group
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. B. Braun Melsungen AG
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ROCHE: KEY EXECUTIVES
TABLE 05. ROCHE: COMPANY SNAPSHOT
TABLE 06. ROCHE: OPERATING SEGMENTS
TABLE 07. ROCHE: PRODUCT PORTFOLIO
TABLE 08. ROCHE: KEY STRATERGIES
TABLE 09. ABBOTT: KEY EXECUTIVES
TABLE 10. ABBOTT: COMPANY SNAPSHOT
TABLE 11. ABBOTT: OPERATING SEGMENTS
TABLE 12. ABBOTT: PRODUCT PORTFOLIO
TABLE 13. ABBOTT: KEY STRATERGIES
TABLE 14. MEDTRONIC: KEY EXECUTIVES
TABLE 15. MEDTRONIC: COMPANY SNAPSHOT
TABLE 16. MEDTRONIC: OPERATING SEGMENTS
TABLE 17. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 18. MEDTRONIC: KEY STRATERGIES
TABLE 19. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 20. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 21. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 22. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 23. SIEMENS HEALTHINEERS: KEY STRATERGIES
TABLE 24. BAYER: KEY EXECUTIVES
TABLE 25. BAYER: COMPANY SNAPSHOT
TABLE 26. BAYER: OPERATING SEGMENTS
TABLE 27. BAYER: PRODUCT PORTFOLIO
TABLE 28. BAYER: KEY STRATERGIES
TABLE 29. NOVO NORDISK: KEY EXECUTIVES
TABLE 30. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 31. NOVO NORDISK: OPERATING SEGMENTS
TABLE 32. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 33. NOVO NORDISK: KEY STRATERGIES
TABLE 34. PENTAX MEDICAL: KEY EXECUTIVES
TABLE 35. PENTAX MEDICAL: COMPANY SNAPSHOT
TABLE 36. PENTAX MEDICAL: OPERATING SEGMENTS
TABLE 37. PENTAX MEDICAL: PRODUCT PORTFOLIO
TABLE 38. PENTAX MEDICAL: KEY STRATERGIES
TABLE 39. OPTIMEDIS: KEY EXECUTIVES
TABLE 40. OPTIMEDIS: COMPANY SNAPSHOT
TABLE 41. OPTIMEDIS: OPERATING SEGMENTS
TABLE 42. OPTIMEDIS: PRODUCT PORTFOLIO
TABLE 43. OPTIMEDIS: KEY STRATERGIES
TABLE 44. ZEISS GROUP: KEY EXECUTIVES
TABLE 45. ZEISS GROUP: COMPANY SNAPSHOT
TABLE 46. ZEISS GROUP: OPERATING SEGMENTS
TABLE 47. ZEISS GROUP: PRODUCT PORTFOLIO
TABLE 48. ZEISS GROUP: KEY STRATERGIES
TABLE 49. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 50. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 51. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 52. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 53. B. BRAUN MELSUNGEN AG: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ROCHE: NET SALES, 2020-2022* ($MILLION)
FIGURE 21. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ABBOTT: NET SALES, 2020-2022* ($MILLION)
FIGURE 24. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. MEDTRONIC: NET SALES, 2020-2022* ($MILLION)
FIGURE 27. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. SIEMENS HEALTHINEERS: NET SALES, 2020-2022* ($MILLION)
FIGURE 30. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. BAYER: NET SALES, 2020-2022* ($MILLION)
FIGURE 33. BAYER: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. NOVO NORDISK: NET SALES, 2020-2022* ($MILLION)
FIGURE 36. NOVO NORDISK: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. NOVO NORDISK: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. PENTAX MEDICAL: NET SALES, 2020-2022* ($MILLION)
FIGURE 39. PENTAX MEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. PENTAX MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. OPTIMEDIS: NET SALES, 2020-2022* ($MILLION)
FIGURE 42. OPTIMEDIS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. OPTIMEDIS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ZEISS GROUP: NET SALES, 2020-2022* ($MILLION)
FIGURE 45. ZEISS GROUP: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ZEISS GROUP: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022* ($MILLION)
FIGURE 48. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us